Literature DB >> 30484244

MALDI Mass Spectrometry Imaging of N-Linked Glycans in Tissues.

Richard R Drake1, Connor A West2, Anand S Mehta2, Peggi M Angel2.   

Abstract

Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) has been used for two decades to profile the glycan constituents of biological samples. An adaptation of the method to tissues, MALDI mass spectrometry imaging (MALDI-MSI), allows high-throughput spatial profiling of hundreds to thousands of molecules within a single thin tissue section. The ability to profile N-glycans within tissues using MALDI-MSI is a recently developed method that allows identification and localization of 40 or more N-glycans. The key component is to apply a molecular coating of peptide-N-glycosidase to tissues, an enzyme that releases N-glycans from their protein carrier. In this chapter, the methods and approaches to robustly and reproducibly generate two-dimensional N-glycan tissue maps by MALDI-MSI workflows are summarized. Current strengths and limitations of the approach are discussed, as well as potential future applications of the method.

Entities:  

Keywords:  Formalin-fixed paraffin-embedded tissue; Fucosylation; Glycomics; Glycoprotein; MALDI imaging mass spectrometry; N-linked glycosylation; Sialylation

Mesh:

Substances:

Year:  2018        PMID: 30484244     DOI: 10.1007/978-981-13-2158-0_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

Review 1.  Glycomics and glycoproteomics of viruses: Mass spectrometry applications and insights toward structure-function relationships.

Authors:  John F Cipollo; Lisa M Parsons
Journal:  Mass Spectrom Rev       Date:  2020-04-29       Impact factor: 10.946

Review 2.  Proteomics, Glycomics, and Glycoproteomics of Matrisome Molecules.

Authors:  Rekha Raghunathan; Manveen K Sethi; Joshua A Klein; Joseph Zaia
Journal:  Mol Cell Proteomics       Date:  2019-08-30       Impact factor: 5.911

3.  Antibody Panel Based N-Glycan Imaging for N-Glycoprotein Biomarker Discovery.

Authors:  Alyson P Black; Peggi M Angel; Richard R Drake; Anand S Mehta
Journal:  Curr Protoc Protein Sci       Date:  2019-12

Review 4.  Glycosylation and its implications in breast cancer.

Authors:  Danielle A Scott; Richard R Drake
Journal:  Expert Rev Proteomics       Date:  2019-07-25       Impact factor: 3.940

Review 5.  Applications and continued evolution of glycan imaging mass spectrometry.

Authors:  Colin T McDowell; Xiaowei Lu; Anand S Mehta; Peggi M Angel; Richard R Drake
Journal:  Mass Spectrom Rev       Date:  2021-08-15       Impact factor: 10.946

6.  Metabolic Links to Socioeconomic Stresses Uniquely Affecting Ancestry in Normal Breast Tissue at Risk for Breast Cancer.

Authors:  Denys Rujchanarong; Danielle Scott; Yeonhee Park; Sean Brown; Anand S Mehta; Richard Drake; George E Sandusky; Harikrishna Nakshatri; Peggi M Angel
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

7.  On-tissue amidation of sialic acid with aniline for sensitive imaging of sialylated N-glycans from FFPE tissue sections via MALDI mass spectrometry.

Authors:  Hua Zhang; Xudong Shi; Yuan Liu; Bin Wang; Meng Xu; Nathan V Welham; Lingjun Li
Journal:  Anal Bioanal Chem       Date:  2022-01-24       Impact factor: 4.478

8.  How else can we approach prostate cancer biomarker discovery?

Authors:  Richard R Drake; Peggi M Angel; Jennifer Wu; Russell K Pachynski; Joseph E Ippolito
Journal:  Expert Rev Mol Diagn       Date:  2019-09-10       Impact factor: 5.225

9.  Serial in-solution digestion protocol for mass spectrometry-based glycomics and proteomics analysis.

Authors:  Manveen K Sethi; Margaret Downs; Joseph Zaia
Journal:  Mol Omics       Date:  2020-04-20

10.  Importance of glycosylation in the interaction of Tamm-Horsfall protein with collectin-11 and acute kidney injury.

Authors:  Kunjing Gong; Min Xia; Yaqin Wang; Lufeng Bai; Wantao Ying; Fengxue Zhu; Yuqing Chen
Journal:  J Cell Mol Med       Date:  2020-02-11       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.